Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00359099 · ClinicalTrials.gov registry record
Hepatitis C in Adults Who Underwent Congenital Heart Surgery Before Screening
A clinical trial, sponsored by Emory University.
- Terminated
- Registry status
- 1,000
- Enrollment target
NCT00359099: Clinical Trial study, sponsored by Emory University.
NCT00359099 is a clinical trial that was terminated before completion, run by Emory University. The registered enrollment target is 1,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00359099 was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
This is a retrospective chart review. We hypothesize that patients who have undergone congenital heart surgery, prior to screening of blood products have a significant risk of hepatitis C infection and all such patients would benefit from screening for hepatitis C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 1980-01 |
| Est. Completion | 2006-07 |
Why NCT00359099 stopped before completion
NCT00359099 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00359099 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00359099 about?
NCT00359099 is a clinical study titled "Hepatitis C in Adults Who Underwent Congenital Heart Surgery Before Screening". This is a retrospective chart review. We hypothesize that patients who have undergone congenital heart surgery, prior to screening of blood products have a significant risk of hepatitis C infection and all such patients would benefit from screening for hepatitis C.
What is the current status of trial NCT00359099?
This trial is currently terminated. The enrollment target is 1,000 participants. The study started on 1980-01. Estimated completion is 2006-07.
Who is sponsoring clinical trial NCT00359099?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia